Search - tctmd.com

Displaying 541 - 560 of 606

Sort: Relevancy | Date

Presentation SIF 2017

Bicuspid Aortic Valve Disease and TAVR

Presenter: Michael J. Reardon

March 11, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Presentation SIF 2017

While We Like Having Surgeons Around, We Wouldn’t Say We ‘Need’ Them…..

Presenter: David L. Brown

March 09, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

February 27, 2017

News Daily News

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Shelley Wood

February 23, 2017

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Conference News CRT 2017

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Michael O'Riordan

February 21, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

Presentation JIM 2017

The Chimney Technique During “Valve in Valve” TAVR in Stentless Freestyle

Presenter: Orazio Valsecchi, Angelina Vassileva

February 11, 2017

Presentation JIM 2017

In TAVR Know Thy Snare!

Presenter: Ioannis Iakovou

February 11, 2017

Presentation JIM 2017

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Presenter: Alberto Cremonesi

February 10, 2017

Presentation JIM 2017

Portico Valve for TAVI

Presenter: Augusto Pichard

February 10, 2017

Presentation JIM 2017

The Valve Medical Low-Profile Modular TAVR System: Fim Updates

Presenter: Martin B. Leon

February 10, 2017

Presentation JIM 2017

TAVR: The Value of Predilatation

Presenter: Oscar A. Mendiz

February 10, 2017

Presentation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

February 09, 2017

Presentation

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Presenter: Jeffrey Popma

February 09, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

Advertisement

Bicuspid Aortic Valve Disease and TAVR

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

While We Like Having Surgeons Around, We Wouldn’t Say We ‘Need’ Them…..

TCTMD’s Top 10 Most Popular Stories for February 2017

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

The Chimney Technique During “Valve in Valve” TAVR in Stentless Freestyle

In TAVR Know Thy Snare!

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Portico Valve for TAVI

The Valve Medical Low-Profile Modular TAVR System: Fim Updates

TAVR: The Value of Predilatation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content